Document is current
Any future updates will be listed below
-
Authors
Sidorenkov, Grigory https://orcid.org/0000-0002-1926-8862
Stadhouders, Ralph
Jacobs, Colin
Mohamed Hoesein, Firdaus A.A.
Gietema, Hester A.
Nackaerts, Kristiaan
Saghir, Zaigham
Heuvelmans, Marjolein A.
Donker, Hylke C.
Aerts, Joachim G.
Vermeulen, Roel
Uitterlinden, Andre
Lenters, Virissa
van Rooij, Jeroen
Schaefer-Prokop, Cornelia
Groen, Harry J.M.
de Jong, Pim A.
Cornelissen, Robin
Prokop, Mathias
de Bock, Geertruida H.
Vliegenthart, Rozemarijn https://orcid.org/0000-0002-7262-3376
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (KWF Kankerbestrijding)
- License Information
-
More Information
Article History
Received: 9 November 2022
Accepted: 31 January 2023
First Online: 21 March 2023
Declarations
:
: Nackaerts K is on the board of directors of VRGT (Flemish Soc of Respir Health & Tobaccology); participates on the advisory boards of AMGEN and BMS; received payments for lectures in BMS, MSD, ERS Online course. Schaefer-Prokop C is a president of Fleischner Society; received consulting fees from Philips Medical System on Clinical Decision Support. Aerts JG is on the advisory board of Eli-Lilly, Amphora, BIOCAD, MSD; received payments as a speaker at Eli-Lilly, MSD, BIOCAD. Cornelissen R received consulting fees from Janssen, MSD, Spectrum. Groen HJM: received grant from Novartis for the University Medical Center Groningen, received consulting fees from Eli-Lilly. Saghir Z is a Chairman of Danish Lung Cancer Group Screening Committee; received payments for lectures in Pfizer ApS, AstraZeneca A/S, Amgen. Prokop M is a president of Dutch Society of Radiology (NVvR); received payments as a speaker at Canon Medical Systems and Siemens Healthineers Vliegenthart R received payments as a speaker for Siemens Healthineers and Bayer. Other authors have no relevant financial or non-financial interests to disclose.
